Set-of-Mark extraction review — before (table + bounding box) | after (final markdown)

Left: the page cropped around the table with its final boundary (content_region, the corrected end of the table) drawn; the crop extends a little below so any footnotes sit visibly outside the box. Right: the final corrected markdown. One row per table.

ac4549bb7d78177d.pdf

3 tables

p2 · table 1 · Looking Ahead: Second Quarter 2026 Guidance

units=(none) · flavor=stream · camelot_accuracy=95.9 · llm_corrected=True

before — table + bounding box

after — final markdown

For the Three Months EndedLow June 30, 2026Mid June 30, 2026High June 30, 2026
Net income$ 18,210$ 19,372$ 20,534
Net (income) loss attributable to Series A preferred stockholders(874 )(874 )(874 )
Net (income) loss attributable to Series B preferred stockholders(9,030 )(9,030 )(9,030 )
Net (income) loss attributable to Series C preferred stockholders(803 )(803 )(803 )
Net income attributable to common stockholders7,5038,6659,827
Adjustments:
Amortization of stock-based compensation1,6561,6561,656
EAD$ 9,159$ 10,321$ 11,483
Weighted average common shares outstanding - basic18,60518,60518,605
Weighted average common shares outstanding - diluted53,79953,79953,799
Shares attributable to potential redemption of Series B preferred(27,451 )(27,451 )(27,451 )
Shares attributable to potential redemption of Series C preferred(2,524 )(2,524 )(2,524 )
Adjusted weighted average common shares outstanding - diluted (1)23,82423,82423,824
EPS per Weighted Average Share - diluted$ 0.32$ 0.34$ 0.37
EAD per diluted common share (1)$ 0.38$ 0.43$ 0.48
EPS Dividend Coverage Ratio0.64 x0.68 x0.74 x
EAD Dividend Coverage Ratio (1)0.76 x0.86 x0.96 x

p3 · table 2 · Cash Available for Distribution

units=(none) · flavor=stream · camelot_accuracy=97.7 · llm_corrected=True

before — table + bounding box

after — final markdown

For the Three Months EndedLow June 30, 2026Mid June 30, 2026High June 30, 2026
EAD$ 9,159$ 10,321$ 11,483
Adjustments:
Amortization of premiums2,9252,9252,925
Accretion of discounts(1,494 )(1,494 )(1,494 )
Amortization and depreciation1,0681,0681,068
CAD$ 11,658$ 12,820$ 13,982
Weighted average common shares outstanding - basic18,60518,60518,605
Weighted average common shares outstanding - diluted53,79953,79953,799
Shares attributable to potential redemption of Series B preferred(27,451 )(27,451 )(27,451 )
Shares attributable to potential redemption of Series C preferred(2,524 )(2,524 )(2,524 )
Adjusted weighted average common shares outstanding - diluted (1)23,82423,82423,824
EPS per Weighted Average Share - diluted$ 0.32$ 0.34$ 0.37
CAD per diluted common share (1)$ 0.49$ 0.54$ 0.59
EPS Dividend Coverage Ratio0.64 x0.68 x0.74 x
CAD Dividend Coverage Ratio (1)0.98 x1.08 x1.18 x

p4 · table 3 · Reconciliations of Non-GAAP Financial Measures

units=(in thousands, except per share amounts) · flavor=stream · camelot_accuracy=96.8 · llm_corrected=True

before — table + bounding box

after — final markdown

For the Three Months Ended March 31, 2026For the Three Months Ended March 31, 2025
Net income attributable to common stockholders$ 10,040$ 16,518
Net income attributable to redeemable noncontrolling interests2,3664,163
Adjustments
Amortization of stock-based compensation1,4051,283
Provision for (reversal of) credit losses(2,983 )3,625
Equity in (income) losses of equity method investments(54 )(53 )
Unrealized (gains) or losses (1)(746 )(15,861 )
EAD$ 10,028$ 9,675
EAD per Diluted Common Share$ 0.43$ 0.41
Adjustments
Amortization of premiums3,9202,262
Accretion of discounts(1,883 )(2,540 )
Depreciation and amortization of real estate investments1,4261,079
Amortization of deferred financing costs—12
CAD$ 13,491$ 10,488
CAD per Diluted Common Share$ 0.58$ 0.45
Weighted-average common shares outstanding - basic18,60517,516
Weighted-average common shares outstanding - diluted51,45636,049
Shares attributable to potential redemption of Series B Preferred(27,518 )(12,652 )
Shares attributable to potential redemption of Series C Preferred(806 )—
Adjusted weighted-average common shares outstanding - diluted (2)23,13223,397